NMPA Approval

Urapidil Sustained-release Capsules

Approval Number

国药准字H20070161

Company西安远大德天药业股份有限公司

Registration Date

November 16, 2021

Previous Approval Numbers

国药准字H20070161

Drug Information

Generic Name

乌拉地尔缓释胶囊

Dosage Form

胶囊剂(缓释)

Strength

30mg

Drug Type

化学药品

Registration Date

November 16, 2021

Company Information

Applicant Company

Company Name西安远大德天药业股份有限公司

Company Address

西安高新技术产业开发区新型工业园创新路9号

Manufacturing Company

Company Name西安远大德天药业股份有限公司

Company Address

西安高新技术产业开发区新型工业园创新路9号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

乌拉地尔缓释胶囊 - NMPA 批准文号 | MedPath